Recommendations for reproducibility of cerebrospinal fluid extracellular vesicle studies
暂无分享,去创建一个
R. Nieuwland | T. Ikezu | K. Vekrellis | J. Saugstad | U. Sandau | Júlia Costa | Paola Loreto Palacio | H. Su | Trevor J. McFarland | John P. Nolan | Laura J. Vella | Hannah K Jackson | Andrew F. Hill | Setty M Magaña | Lissette Retana Moreira | Joseph F Quinn | Kendall R Van Keuren-Jensen | Joanna Palade | Eric A. Sribnick | Beth Coyle | You Yang | Juan M Falcón-Perez
[1] D. Hoja-Łukowicz,et al. The hidden potential of glycomarkers: Glycosylation studies in the service of cancer diagnosis and treatment. , 2023, Biochimica et biophysica acta. Reviews on cancer.
[2] M. Thaysen‐Andersen,et al. Critical considerations in N-glycoproteomics. , 2023, Current opinion in chemical biology.
[3] Jennifer C. Jones,et al. A compendium of single extracellular vesicle flow cytometry , 2023, Journal of extracellular vesicles.
[4] Nick C Fox,et al. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease , 2022, Nature Genetics.
[5] Lesley Cheng,et al. Brain Tissue-Derived Extracellular Vesicles in Alzheimer’s Disease Display Altered Key Protein Levels Including Cell Type-Specific Markers , 2022, Journal of Alzheimer's disease : JAD.
[6] K. Datta,et al. Comparative analysis of tangential flow filtration and ultracentrifugation, both combined with subsequent size exclusion chromatography, for the isolation of small extracellular vesicles , 2022, Journal of extracellular vesicles.
[7] M. Marelli,et al. Comparing digital detection platforms in high sensitivity immune‐phenotyping of extracellular vesicles , 2022, Journal of Extracellular Biology.
[8] B. Mollenhauer,et al. CSF-derived extracellular vesicles from patients with Parkinson's disease induce symptoms and pathology. , 2022, Brain : a journal of neurology.
[9] B. Heijs,et al. High-Throughput Glycomic Methods , 2022, Chemical reviews.
[10] B. Lomonte,et al. Characterization of Extracellular Vesicles Secreted by a Clinical Isolate of Naegleria fowleri and Identification of Immunogenic Components within Their Protein Cargo , 2022, Biology.
[11] D. Galasko,et al. Differential Effects of APOE Genotype on MicroRNA Cargo of Cerebrospinal Fluid Extracellular Vesicles in Females With Alzheimer’s Disease Compared to Males , 2022, Frontiers in Cell and Developmental Biology.
[12] A. Castañeyra-Perdomo,et al. AQP4 labels a subpopulation of white matter-dependent glial radial cells affected by pediatric hydrocephalus, and its expression increased in glial microvesicles released to the cerebrospinal fluid in obstructive hydrocephalus , 2022, Acta Neuropathologica Communications.
[13] Mario Kurtjak,et al. Extracellular Vesicles from Human Cerebrospinal Fluid Are Effectively Separated by Sepharose CL-6B—Comparison of Four Gravity-Flow Size Exclusion Chromatography Methods , 2022, Biomedicines.
[14] Rebecca A. Reiman,et al. A Novel Tissue Atlas and Online Tool for the Interrogation of Small RNA Expression in Human Tissues and Biofluids , 2022, Frontiers in Cell and Developmental Biology.
[15] Jing Ma,et al. Expression Profiles of Exosomal MicroRNAs Derived from Cerebrospinal Fluid in Patients with Congenital Hydrocephalus Determined by MicroRNA Sequencing , 2022, Disease markers.
[16] J. Griffith,et al. Imaging of surface microdomains on individual extracellular vesicles in 3‐D , 2022, Journal of extracellular vesicles.
[17] Y. Mechref,et al. Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers , 2022, Cells.
[18] J. Kawada,et al. MicroRNA expression profiling of cerebrospinal fluid/serum exosomes in children with human herpesvirus 6-associated encephalitis/encephalopathy by high-throughput sequencing , 2022, Journal of NeuroVirology.
[19] Y. Gui,et al. Cerebrospinal Fluid Extracellular Vesicles with Distinct Properties in Autoimmune Encephalitis and Herpes Simplex Encephalitis , 2022, Molecular Neurobiology.
[20] Helle H Damkier,et al. A Brief Overview of the Cerebrospinal Fluid System and Its Implications for Brain and Spinal Cord Diseases , 2022, Frontiers in Human Neuroscience.
[21] H. Struyfs,et al. Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers. , 2022, Brain : a journal of neurology.
[22] Yong Cheng,et al. Metabolomic Identification of Serum Exosome-Derived Biomarkers for Bipolar Disorder , 2022, Oxidative medicine and cellular longevity.
[23] S. Gygi,et al. Human neural cell type‐specific extracellular vesicle proteome defines disease‐related molecules associated with activated astrocytes in Alzheimer's disease brain , 2022, Journal of extracellular vesicles.
[24] B. Teter,et al. Multi-Omics Analysis of Microglial Extracellular Vesicles From Human Alzheimer’s Disease Brain Tissue Reveals Disease-Associated Signatures , 2021, Frontiers in Pharmacology.
[25] G. Church,et al. Framework for rapid comparison of extracellular vesicle isolation methods , 2021, eLife.
[26] Tianbai Li,et al. Role of Glia-Derived Extracellular Vesicles in Neurodegenerative Diseases , 2021, Frontiers in Aging Neuroscience.
[27] R. Vandenbroucke,et al. Involvement of the Choroid Plexus in the Pathogenesis of Niemann-Pick Disease Type C , 2021, Frontiers in Cellular Neuroscience.
[28] Matthew S. Gentry,et al. Emerging roles of N-linked glycosylation in brain physiology and disorders , 2021, Trends in Endocrinology & Metabolism.
[29] S. Kristensen,et al. Characterising Alzheimer's disease through integrative NMR- and LC-MS-based metabolomics , 2021, Metabolism open.
[30] Björn M. Burmann,et al. Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders , 2021, Acta Neuropathologica.
[31] B. Kuster,et al. High sensitivity glycomics in biomedicine , 2021, Mass spectrometry reviews.
[32] R. Carney,et al. Surface enhanced Raman scattering of extracellular vesicles for cancer diagnostics despite isolation dependent lipoprotein contamination , 2021, Nanoscale.
[33] R. Vandenbroucke,et al. Importance of extracellular vesicle secretion at the blood–cerebrospinal fluid interface in the pathogenesis of Alzheimer’s disease , 2021, Acta neuropathologica communications.
[34] R. Dale,et al. Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease , 2021, Clinical & translational immunology.
[35] Jianye Xu,et al. The dual role of glioma exosomal microRNAs: glioma eliminates tumor suppressor miR-1298-5p via exosomes to promote immunosuppressive effects of MDSCs , 2021, Cell Death & Disease.
[36] Yanhua Qi,et al. Exosomal miR-1246 from glioma patient body fluids drives the differentiation and activation of myeloid-derived suppressor cells. , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.
[37] L. Tan,et al. Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study. , 2021, Journal of Alzheimer's disease : JAD.
[38] L. Tjernberg,et al. What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease? , 2021, Biomolecules.
[39] Guang Yang,et al. The anesthetic sevoflurane induces tau trafficking from neurons to microglia , 2021, Communications Biology.
[40] C. D. Fowler,et al. Huntington's disease mice and human brain tissue exhibit increased G3BP1 granules and TDP43 mislocalization. , 2021, The Journal of clinical investigation.
[41] G. Palmisano,et al. Protein glycosylation in extracellular vesicles: Structural characterization and biological functions. , 2021, Molecular immunology.
[42] M. Mattson,et al. Neuronal and Astrocytic Extracellular Vesicle Biomarkers in Blood Reflect Brain Pathology in Mouse Models of Alzheimer’s Disease , 2021, Cells.
[43] Jason J. Davis,et al. Validation of α‐Synuclein in L1CAM‐Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes , 2021, Movement disorders : official journal of the Movement Disorder Society.
[44] L. Mahal,et al. Sweet systems: technologies for glycomic analysis and their integration into systems biology , 2021, Critical reviews in biochemistry and molecular biology.
[45] T. Montine,et al. Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein–Containing Extracellular Vesicles , 2021, Neurology.
[46] Yue Zhao,et al. ABCA1-Labeled Exosomes in Serum Contain Higher MicroRNA-193b Levels in Alzheimer's Disease , 2021, BioMed research international.
[47] Maria Teresa Dell'Anno,et al. Proteomics Profiling of Neuron-Derived Small Extracellular Vesicles from Human Plasma: Enabling Single-Subject Analysis , 2021, International journal of molecular sciences.
[48] A. Kaelin-Lang,et al. Profiling Inflammatory Extracellular Vesicles in Plasma and Cerebrospinal Fluid: An Optimized Diagnostic Model for Parkinson’s Disease , 2021, Biomedicines.
[49] L. Ramenghi,et al. Potential biomarkers of childhood brain tumor identified by proteomics of cerebrospinal fluid from extraventricular drainage (EVD) , 2021, Scientific Reports.
[50] B. Yoo,et al. Molecular Signature of Extracellular Vesicular Small Non-Coding RNAs Derived from Cerebrospinal Fluid of Leptomeningeal Metastasis Patients: Functional Implication of miR-21 and Other Small RNAs in Cancer Malignancy , 2021, Cancers.
[51] C. Reis,et al. Glycosylation of Cancer Extracellular Vesicles: Capture Strategies, Functional Roles and Potential Clinical Applications , 2021, Cells.
[52] Kentaro Otake,et al. Analysis of Cerebrospinal Fluid Extracellular Vesicles by Proximity Extension Assay: A Comparative Study of Four Isolation Kits , 2020, International journal of molecular sciences.
[53] K. Pienta,et al. Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium , 2020, Journal of extracellular vesicles.
[54] E. van der Pol,et al. MIFlowCyt‐EV: The Next Chapter in the Reporting and Reliability of Single Extracellular Vesicle Flow Cytometry Experiments , 2020, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[55] Quanzhong Tang,et al. Metabolomic Identification of Exosome-Derived Biomarkers for Schizophrenia: A Large Multicenter Study. , 2020, Schizophrenia bulletin.
[56] H. Hirano,et al. Proteomic analysis of exosome-enriched fractions derived from cerebrospinal fluid of amyotrophic lateral sclerosis patients , 2020, Neuroscience Research.
[57] G. Boons,et al. Identification of Isomeric N‐Glycans by Conformer Distribution Fingerprinting using Ion Mobility Mass Spectrometry , 2020, Chemistry.
[58] A. Janowsky,et al. Methamphetamine use alters human plasma extracellular vesicles and their microRNA cargo: An exploratory study , 2020, Journal of extracellular vesicles.
[59] Yang Cai,et al. Exosomal LGALS9 in the cerebrospinal fluid of glioblastoma patients suppressed dendritic cell antigen presentation and cytotoxic T-cell immunity , 2020, Cell Death & Disease.
[60] Jinzhong Xu,et al. Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation , 2020, JAMA network open.
[61] S. Qi,et al. A Panel of Exosome-Derived miRNAs of Cerebrospinal Fluid for the Diagnosis of Moyamoya Disease , 2020, Frontiers in Neuroscience.
[62] Suqin Jin,et al. Detection and significance of exosomal mRNA expression profiles in the cerebrospinal fluid of patients with meningeal carcinomatosis , 2020, Journal of Molecular Neuroscience.
[63] Jason J. Davis,et al. Facile Impedimetric Analysis of Neuronal Exosome Markers in Parkinson’s Disease Diagnostics , 2020, Analytical chemistry.
[64] Nicholas M Riley,et al. A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry-based Glycoproteomics. , 2020, Molecular & cellular proteomics : MCP.
[65] H. Schipper,et al. Characterization and heme oxygenase‐1 content of extracellular vesicles in human biofluids , 2020, Journal of neurochemistry.
[66] Y. Abe,et al. O-Glycan-Altered Extracellular Vesicles: A Specific Serum Marker Elevated in Pancreatic Cancer , 2020, Cancers.
[67] S. Gygi,et al. Proteomic Profiling of Extracellular Vesicles Derived from Cerebrospinal Fluid of Alzheimer’s Disease Patients: A Pilot Study , 2020, Cells.
[68] C. Masters,et al. Characterization of brain‐derived extracellular vesicle lipids in Alzheimer's disease , 2020, bioRxiv.
[69] M. Turner,et al. CSF extracellular vesicle proteomics demonstrates altered protein homeostasis in amyotrophic lateral sclerosis , 2020, Clinical Proteomics.
[70] A. Regev,et al. L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma , 2020, Nature Methods.
[71] B. Yoo,et al. Nanoparticles in 472 Human Cerebrospinal Fluid: Changes in Extracellular Vesicle Concentration and miR-21 Expression as a Biomarker for Leptomeningeal Metastasis , 2020, Cancers.
[72] Ying Wang,et al. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer’s dementia , 2020, Translational Neurodegeneration.
[73] S. Kim,et al. Exosomal microRNA expression profiles of cerebrospinal fluid in febrile seizure patients , 2020, Seizure.
[74] W. Buchberger,et al. Evaluation and optimization of common lipid extraction methods in cerebrospinal fluid samples. , 2020, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[75] S. Buch,et al. Extracellular Vesicles in Viral Infections of the Nervous System , 2020, Viruses.
[76] P. Lőrincz,et al. MicroRNA-181a as novel liquid biopsy marker of central nervous system involvement in pediatric acute lymphoblastic leukemia , 2020, Journal of Translational Medicine.
[77] A. Ivanov,et al. Technologies and Standardization in Research on Extracellular Vesicles , 2020, Trends in Biotechnology.
[78] I. Solomon. Molecular and Histologic Diagnosis of Central Nervous System Infections. , 2020, Surgical pathology clinics.
[79] P. Cox,et al. An miRNA fingerprint using neural-enriched extracellular vesicles from blood plasma: towards a biomarker for amyotrophic lateral sclerosis/motor neuron disease , 2020, Open Biology.
[80] N. Tan,et al. Quantitative proteomic characterization of microvesicles/exosomes from the cerebrospinal fluid of patients with acute bilirubin encephalopathy , 2020, Molecular medicine reports.
[81] Maxim N. Artyomov,et al. Single-cell RNA-seq analysis of human CSF microglia and myeloid cells in neuroinflammation , 2020, Neurology: Neuroimmunology & Neuroinflammation.
[82] Q. Dong,et al. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease. , 2020, Brain : a journal of neurology.
[83] U. Cavallaro,et al. Different Shades of L1CAM in the Pathophysiology of Cancer Stem Cells , 2020, Journal of clinical medicine.
[84] Jason J. Davis,et al. Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism , 2020, Journal of Neurology, Neurosurgery, and Psychiatry.
[85] M. de Carvalho,et al. Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases , 2020, Scientific Reports.
[86] J. Liu,et al. A longitudinal study on α‐synuclein in plasma neuronal exosomes as a biomarker for Parkinson’s disease development and progression , 2020, European journal of neurology.
[87] U. Frey,et al. Extracellular vesicles isolated from patients undergoing remote ischemic preconditioning decrease hypoxia-evoked apoptosis of cardiomyoblasts after isoflurane but not propofol exposure , 2020, PloS one.
[88] A. Emili,et al. Assessment of separation methods for extracellular vesicles from human and mouse brain tissues and human cerebrospinal fluids. , 2020, Methods.
[89] X. Breakefield,et al. Glioblastomas exploit truncated O-linked glycans for local and distant immune modulation via the macrophage galactose-type lectin , 2020, Proceedings of the National Academy of Sciences.
[90] C. Richardson,et al. A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum , 2020, Scientific Reports.
[91] W. Stoorvogel,et al. A novel three step protocol to isolate extracellular vesicles from plasma or cell culture medium with both high yield and purity , 2020, Journal of extracellular vesicles.
[92] Ashley M. Laughney,et al. L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer , 2020, Nature Cancer.
[93] Lesley Cheng,et al. Influence of species and processing parameters on recovery and content of brain tissue-derived extracellular vesicles , 2020, bioRxiv.
[94] Romaric Lacroix,et al. MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments , 2020, Journal of extracellular vesicles.
[95] S. Morgello,et al. Proteomic analysis of cerebrospinal fluid extracellular vesicles reveals synaptic injury, inflammation, and stress response markers in HIV patients with cognitive impairment , 2019, Journal of Neuroinflammation.
[96] D. Bennett,et al. miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer’s Patients , 2019, Front. Neurosci..
[97] P. Williamson,et al. Quantifications of CSF Apoptotic Bodies Do Not Provide Clinical Value in Multiple Sclerosis , 2019, Front. Neurol..
[98] P. Shaw,et al. Disrupted glycosylation of lipids and proteins is a cause of neurodegeneration , 2019, Brain : a journal of neurology.
[99] Philip S. Insel,et al. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease , 2019, EMBO molecular medicine.
[100] P. Siljander,et al. Metabolomics Applied to the Study of Extracellular Vesicles , 2019, Metabolites.
[101] Oliver C. Grant,et al. O-glycosylation on cerebrospinal fluid and plasma Apolipoprotein E differs in the lipid binding domain. , 2019, Glycobiology.
[102] S. Gygi,et al. Proteomic Profiling of Extracellular Vesicles Isolated From Cerebrospinal Fluid of Former National Football League Players at Risk for Chronic Traumatic Encephalopathy , 2019, Front. Neurosci..
[103] W. Maier,et al. A combined miRNA–piRNA signature to detect Alzheimer’s disease , 2019, Translational Psychiatry.
[104] Qiwei Yang,et al. Exosomal Circular RNA as a Biomarker Platform for the Early Diagnosis of Immune-Mediated Demyelinating Disease , 2019, Front. Genet..
[105] K. Choong,et al. Collection and Analyses of Cerebrospinal Fluid for Pediatric Translational Research. , 2019, Pediatric neurology.
[106] R. Petersen,et al. Population-Based Evaluation of Lumbar Puncture Opening Pressures , 2019, Front. Neurol..
[107] J. Falcón-Pérez,et al. Assessing the role of surface glycans of extracellular vesicles on cellular uptake , 2019, Scientific Reports.
[108] Zhenping Liu,et al. Rapid and Quantitative Analysis of Exosomes by a Chemiluminescence Immunoassay Using Superparamagnetic Iron Oxide Particles. , 2019, Journal of biomedical nanotechnology.
[109] M. Onofrj,et al. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis. , 2019, Journal of proteomics.
[110] M. Kiebler,et al. Choroid plexus‐derived miR‐204 regulates the number of quiescent neural stem cells in the adult brain , 2019, The EMBO journal.
[111] A. Raval,et al. Sexual dimorphism in inflammasome-containing extracellular vesicles and the regulation of innate immunity in the brain of reproductive senescent females , 2019, Neurochemistry International.
[112] S. Tong,et al. When Ventricular Cerebrospinal Fluid Assessment Misleads: Basal Meningitis and the Importance of Lumbar Puncture Sampling , 2019, Open forum infectious diseases.
[113] K. Estrada,et al. BIN1 favors the spreading of Tau via extracellular vesicles , 2019, Scientific Reports.
[114] P. Widłak,et al. Metabolome of Exosomes: Focus on Vesicles Released by Cancer Cells and Present in Human Body Fluids , 2019, International journal of molecular sciences.
[115] J. Falcón-Pérez,et al. A Comprehensive Study of Vesicular and Non-Vesicular miRNAs from a Volume of Cerebrospinal Fluid Compatible with Clinical Practice , 2019, Theranostics.
[116] S. Vakhrushev,et al. Different isolation approaches lead to diverse glycosylated extracellular vesicle populations , 2019, Journal of extracellular vesicles.
[117] A. Hrishi,et al. Cerebrospinal Fluid (CSF) Analysis and Interpretation in Neurocritical Care for Acute Neurological Conditions , 2019, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.
[118] K. Xia,et al. Identification of a potential exosomal biomarker in spinocerebellar ataxia Type 3/Machado-Joseph disease. , 2019, Epigenomics.
[119] P. Lewczuk,et al. Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein , 2019, Scientific Reports.
[120] P. Lewczuk,et al. Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease , 2019, Alzheimer's Research & Therapy.
[121] N. Taniguchi,et al. N‐glycome inheritance from cells to extracellular vesicles in B16 melanomas , 2019, FEBS letters.
[122] Dylan T Burnette,et al. Reassessment of Exosome Composition , 2019, Cell.
[123] E. Buzás,et al. Systems biology approaches to investigating the roles of extracellular vesicles in human diseases , 2019, Experimental & Molecular Medicine.
[124] D. Galasko,et al. Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid. , 2019, Journal of Alzheimer's disease : JAD.
[125] V. Fossati,et al. Cerebrospinal fluid biomarkers link toxic astrogliosis and microglial activation to multiple sclerosis severity. , 2019, Multiple sclerosis and related disorders.
[126] M. de Carvalho,et al. Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis , 2019, Molecular Neurobiology.
[127] P. Lučin,et al. Severe Traumatic Brain Injury Induces Early Changes in the Physical Properties and Protein Composition of Intracranial Extracellular Vesicles. , 2019, Journal of neurotrauma.
[128] H. Kamiguchi,et al. Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid , 2019, BMC Medical Genomics.
[129] A. Clayton,et al. Exosomes populate the cerebrospinal fluid of preterm infants with post-haemorrhagic hydrocephalus , 2019, International Journal of Developmental Neuroscience.
[130] D. Yellon,et al. Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and functional potential , 2018, Journal of extracellular vesicles.
[131] A. Pitkänen,et al. Precipitation-based extracellular vesicle isolation from rat plasma co-precipitate vesicle-free microRNAs , 2018, Journal of extracellular vesicles.
[132] S. Morgello,et al. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy , 2018, AIDS.
[133] Hsu-hsin Chen,et al. Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease , 2018, Acta Neuropathologica.
[134] M. Smrčka,et al. MicroRNA isolation and quantification in cerebrospinal fluid: A comparative methodical study , 2018, PloS one.
[135] M. Turner,et al. UFLC‐Derived CSF Extracellular Vesicle Origin and Proteome , 2018, Proteomics.
[136] Jing Xu,et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.
[137] S. Realmuto,et al. Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Composition of Extracellular Vesicles in Cerebrospinal Fluid , 2018, Front. Cell. Neurosci..
[138] M. Rösslein,et al. Characterisation of particles in solution – a perspective on light scattering and comparative technologies , 2018, Science and technology of advanced materials.
[139] Masanori Arita,et al. MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines1 , 2018, Journal of Lipid Research.
[140] K. Blennow,et al. CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease , 2018, Neurology.
[141] Maria K. Lehtinen,et al. The ESCRT-III Protein CHMP1A Mediates Secretion of Sonic Hedgehog on a Distinctive Subtype of Extracellular Vesicles , 2018, Cell reports.
[142] J. Cummings. The National Institute on Aging—Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials , 2018, Alzheimer's & Dementia.
[143] Liang Li,et al. High-Performance Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry for Exosome Metabolomics. , 2018, Analytical chemistry.
[144] M. Glatzel,et al. N-Glycosylation of Extracellular Vesicles from HEK-293 and Glioma Cell Lines. , 2018, Analytical chemistry.
[145] Ana Gabriela Henriques,et al. Exosome isolation from distinct biofluids using precipitation and column-based approaches , 2018, PloS one.
[146] Carolyn A. Harris,et al. Cerebrospinal fluid circulation: What do we know and how do we know it? , 2018, Brain circulation.
[147] Christopher J. Lyon,et al. Role of Extracellular Vesicles in Viral and Bacterial Infections: Pathogenesis, Diagnostics, and Therapeutics , 2018, Theranostics.
[148] K. Selmaj,et al. Multiple sclerosis: Serum-derived exosomes express myelin proteins , 2018, Multiple sclerosis.
[149] P. Dong,et al. Tumor-associated macrophages-derived exosomes promote the migration of gastric cancer cells by transfer of functional Apolipoprotein E , 2018, Cell Death & Disease.
[150] H. Tateno,et al. Glycome analysis of extracellular vesicles derived from human induced pluripotent stem cells using lectin microarray , 2018, Scientific Reports.
[151] J. Falcón-Pérez,et al. Glycosylation of extracellular vesicles: current knowledge, tools and clinical perspectives , 2018, Journal of extracellular vesicles.
[152] André M. N. Silva,et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation , 2018, Nature Cell Biology.
[153] D. Selkoe,et al. Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles , 2018, International journal of molecular sciences.
[154] O. Slabý,et al. Cerebrospinal fluid microRNAs as diagnostic biomarkers in brain tumors , 2018, Clinical chemistry and laboratory medicine.
[155] M. Onofrj,et al. Enhanced release of acid sphingomyelinase-enriched exosomes generates a lipidomics signature in CSF of Multiple Sclerosis patients , 2018, Scientific Reports.
[156] Hakho Lee,et al. New Technologies for Analysis of Extracellular Vesicles. , 2018, Chemical reviews.
[157] Henrik Zetterberg,et al. Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease , 2018, Neurology.
[158] T. Patel,et al. Large Differences in Small RNA Composition Between Human Biofluids , 2018, bioRxiv.
[159] Kevin K. W. Wang,et al. Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury , 2018, Molecular Neurobiology.
[160] J. Wilkins,et al. Application of Metabolomics in Alzheimer’s Disease , 2018, Front. Neurol..
[161] Pieter Vermeersch,et al. Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma , 2018, Journal of Translational Medicine.
[162] Yanan Li,et al. The role of exosomes derived from cerebrospinal fluid of spinal cord injury in neuron proliferation in vitro , 2018, Artificial cells, nanomedicine, and biotechnology.
[163] D. Galasko,et al. Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotype , 2018, Autophagy.
[164] Y. Mechref,et al. Glycosylation Changes in Brain Cancer. , 2017, ACS chemical neuroscience.
[165] William T. Hu,et al. Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers , 2017, Alzheimer's Research & Therapy.
[166] C. Bettegowda,et al. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients , 2017, Neuro-oncology.
[167] Joanne L Welton,et al. Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis , 2017, Journal of extracellular vesicles.
[168] O. Kallioniemi,et al. Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes , 2017, Theranostics.
[169] K. Kultima,et al. Increased Release of Apolipoprotein E in Extracellular Vesicles Following Amyloid-β Protofibril Exposure of Neuroglial Co-Cultures , 2017, Journal of Alzheimer's disease : JAD.
[170] Júlia Costa. Glycoconjugates from extracellular vesicles: Structures, functions and emerging potential as cancer biomarkers. , 2017, Biochimica et biophysica acta. Reviews on cancer.
[171] J. Connor,et al. Interleukin-13 conjugated quantum dots for identification of glioma initiating cells and their extracellular vesicles. , 2017, Acta biomaterialia.
[172] T. Montine,et al. Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults , 2017, Alzheimer's Research & Therapy.
[173] D. Galasko,et al. A cerebrospinal fluid microRNA signature as biomarker for glioblastoma , 2017, Oncotarget.
[174] K. Messer,et al. Analysis of extracellular RNA in cerebrospinal fluid , 2017, Journal of extracellular vesicles.
[175] A. Hill,et al. Methodological Guidelines to Study Extracellular Vesicles. , 2017, Circulation research.
[176] M. Bradl,et al. Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases , 2017, Front. Immunol..
[177] G. Szabo,et al. Extracellular vesicle isolation: present and future. , 2017, Annals of translational medicine.
[178] Patrizia Agostinis,et al. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research , 2017, Nature Methods.
[179] Anja Schneider,et al. The release and trans-synaptic transmission of Tau via exosomes , 2017, Molecular Neurodegeneration.
[180] Y. Hayashizaki,et al. Next-generation sequencing-based small RNA profiling of cerebrospinal fluid exosomes , 2017, Neuroscience Letters.
[181] V. Gerzanich,et al. Cerebrospinal fluid hypersecretion in pediatric hydrocephalus. , 2016, Neurosurgical focus.
[182] Su-Hyun Kim,et al. Exosomal proteome analysis of cerebrospinal fluid detects biosignatures of neuromyelitis optica and multiple sclerosis. , 2016, Clinica chimica acta; international journal of clinical chemistry.
[183] G. Jicha,et al. Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[184] R. Vandenbroucke,et al. Identification of a novel mechanism of blood–brain communication during peripheral inflammation via choroid plexus‐derived extracellular vesicles , 2016, EMBO molecular medicine.
[185] M. Esiri,et al. Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies , 2016, Annals of clinical and translational neurology.
[186] M. Ståhlman,et al. The BUME method: a new rapid and simple chloroform-free method for total lipid extraction of animal tissue , 2016, Scientific Reports.
[187] M. Griffin,et al. Getting to know the extracellular vesicle glycome. , 2016, Molecular bioSystems.
[188] J. Rak,et al. Extracellular Vesicles in Brain Tumor Progression , 2016, Cellular and Molecular Neurobiology.
[189] S. Byers,et al. Enabling Metabolomics Based Biomarker Discovery Studies Using Molecular Phenotyping of Exosome-Like Vesicles , 2016, PloS one.
[190] J. Iliff,et al. Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease. , 2016, Biochimica et biophysica acta.
[191] R. McKay,et al. Metabolomics and Its Application to Acute Lung Diseases , 2016, Front. Immunol..
[192] J. Akers,et al. Comparative Analysis of Technologies for Quantifying Extracellular Vesicles (EVs) in Clinical Cerebrospinal Fluids (CSF) , 2016, PloS one.
[193] W. Ashley,et al. Microparticle derived proteins as potential biomarkers for cerebral vasospasm post subarachnoid hemorrhage. A preliminary study , 2016, Clinical Neurology and Neurosurgery.
[194] Michael Y. Wang,et al. Exosome‐mediated inflammasome signaling after central nervous system injury , 2016, Journal of neurochemistry.
[195] B. Mollenhauer,et al. Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies , 2015, Brain : a journal of neurology.
[196] M. Nair,et al. Microglia-derived HIV Nef+ exosome impairment of the blood–brain barrier is treatable by nanomedicine-based delivery of Nef peptides , 2015, Journal of NeuroVirology.
[197] Abeer A. Alhadi,et al. Understanding the chemistry behind the antioxidant activities of butylated hydroxytoluene (BHT): a review. , 2015, European journal of medicinal chemistry.
[198] Henrik Zetterberg,et al. Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction , 2015, PloS one.
[199] T. Jiang,et al. Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients , 2015, Oncotarget.
[200] Sofia B. Carvalho,et al. Extracellular Vesicles from Ovarian Carcinoma Cells Display Specific Glycosignatures , 2015, Biomolecules.
[201] H. Freeze,et al. Neurological aspects of human glycosylation disorders. , 2015, Annual review of neuroscience.
[202] R. Petersen,et al. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study , 2015, Alzheimer's & Dementia.
[203] A. Fagan,et al. Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease. , 2015, JAMA neurology.
[204] I. Nakano,et al. miRNA contents of cerebrospinal fluid extracellular vesicles in glioblastoma patients , 2015, Journal of Neuro-Oncology.
[205] A. Fagan,et al. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease , 2015, Alzheimer's & Dementia.
[206] Enriqueta Casal,et al. Considerations for Applying Metabolomics to the Analysis of Extracellular Vesicles , 2014, Front. Immunol..
[207] David M Feliciano,et al. Cerebrospinal Fluid Extracellular Vesicles Undergo Age Dependent Declines and Contain Known and Novel Non-coding RNAs , 2014, PloS one.
[208] Gabriele Cruciani,et al. LC/MS lipid profiling from human serum: a new method for global lipid extraction , 2014, Analytical and Bioanalytical Chemistry.
[209] T. Lydic,et al. A monophasic extraction strategy for the simultaneous lipidome analysis of polar and nonpolar retina lipids[S] , 2014, Journal of Lipid Research.
[210] Q. Lan,et al. Glioblastoma microvesicles promote endothelial cell proliferation through Akt/beta-catenin pathway. , 2014, International journal of clinical and experimental pathology.
[211] T. J. Cook,et al. Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease , 2014, Acta Neuropathologica.
[212] I. Sargent,et al. Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing , 2014, Journal of thrombosis and haemostasis : JTH.
[213] C. Teunissen,et al. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. , 2014, Journal of proteomics.
[214] Thomas Brinker,et al. A new look at cerebrospinal fluid circulation , 2014, Fluids and Barriers of the CNS.
[215] V. Kopecký,et al. Instability of cerebrospinal fluid after delayed storage and repeated freezing: a holistic study by drop coating deposition Raman spectroscopy , 2014, Clinical chemistry and laboratory medicine.
[216] A. C. Kroksveen,et al. Effects of Blood Contamination and the Rostro-Caudal Gradient on the Human Cerebrospinal Fluid Proteome , 2014, PloS one.
[217] Shiliang Zhang,et al. Embryonic Cerebrospinal Fluid Nanovesicles Carry Evolutionarily Conserved Molecules and Promote Neural Stem Cell Amplification , 2014, PloS one.
[218] R. Nieuwland,et al. Co-isolation of extracellular vesicles and high-density lipoproteins using density gradient ultracentrifugation , 2014, Journal of extracellular vesicles.
[219] R. Nieuwland,et al. Single-step isolation of extracellular vesicles by size-exclusion chromatography , 2014, Journal of extracellular vesicles.
[220] V. Bandaru,et al. A Biological Perspective of CSF Lipids as Surrogate Markers for Cognitive Status in HIV , 2013, Journal of Neuroimmune Pharmacology.
[221] Bob S. Carter,et al. miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development , 2013, PloS one.
[222] Oana A. Tomescu,et al. More than cell dust: microparticles isolated from cerebrospinal fluid of brain injured patients are messengers carrying mRNAs, miRNAs, and proteins. , 2013, Journal of neurotrauma.
[223] L. Liau,et al. BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles , 2013, Molecular therapy. Nucleic acids.
[224] C. Jack,et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.
[225] Sébastien A. Gauthier,et al. The Exosome Secretory Pathway Transports Amyloid Precursor Protein Carboxyl-terminal Fragments from the Cell into the Brain Extracellular Space* , 2012, The Journal of Biological Chemistry.
[226] Taim A. Muayqil,et al. Evidence-based guideline: Diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease , 2012, Neurology.
[227] E. Sverdlov. Amedeo Avogadro's cry: What is 1 µg of exosomes? , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.
[228] A. Vercelli,et al. Myeloid microvesicles are a marker and therapeutic target for neuroinflammation , 2012, Annals of neurology.
[229] Allan R. Jones,et al. An anatomically comprehensive atlas of the adult human brain transcriptome , 2012, Nature.
[230] Sean P. Palecek,et al. Human Blood-Brain Barrier Endothelial Cells Derived from Pluripotent Stem Cells , 2012, Nature Biotechnology.
[231] S. Schwab,et al. Increased membrane shedding – indicated by an elevation of CD133-enriched membrane particles – into the CSF in partial epilepsy , 2012, Epilepsy Research.
[232] J Chazal,et al. Anatomy and physiology of cerebrospinal fluid. , 2011, European annals of otorhinolaryngology, head and neck diseases.
[233] L. Mahal,et al. Identification of a conserved glycan signature for microvesicles. , 2011, Journal of proteome research.
[234] Giovanni B. Frisoni,et al. The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers , 2011, Alzheimer's & Dementia.
[235] D. G. Clark,et al. Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease , 2011, Nature Genetics.
[236] Sascha Keller,et al. Interaction and uptake of exosomes by ovarian cancer cells , 2011, BMC Cancer.
[237] Steven J Collins,et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion , 2011, Nature Medicine.
[238] Paul C Guest,et al. Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia. , 2010, Journal of proteome research.
[239] J. Fleming,et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking , 2009, Neurology.
[240] X. Dong,et al. High concentrations of procoagulant microparticles in the cerebrospinal fluid and peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome. , 2009, Surgical neurology.
[241] J. Rush,et al. The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid , 2009, Cerebrospinal Fluid Research.
[242] A. Hill,et al. Enrichment of prion protein in exosomes derived from ovine cerebral spinal fluid. , 2008, Veterinary immunology and immunopathology.
[243] Paul E. West,et al. A comparison of atomic force microscopy (AFM) and dynamic light scattering (DLS) methods to characterize nanoparticle size distributions , 2008 .
[244] Thomas Brinker,et al. Multiplicity of cerebrospinal fluid functions: New challenges in health and disease , 2008, Cerebrospinal Fluid Research.
[245] M. Wassef,et al. The particles of the embryonic cerebrospinal fluid: How could they influence brain development? , 2008, Brain Research Bulletin.
[246] J. Freyssinet,et al. Generation of procoagulant microparticles in cerebrospinal fluid and peripheral blood after traumatic brain injury. , 2008, The Journal of trauma.
[247] W. Hacke,et al. The Stem Cell Marker Prominin‐1/CD133 on Membrane Particles in Human Cerebrospinal Fluid Offers Novel Approaches for Studying Central Nervous System Disease , 2008, Stem cells.
[248] Victoria Wong. Medication use as a confounding factor in the use of the cerebrospinal fluid tau/beta-amyloid42 ratio. , 2007, Archives of neurology.
[249] R. M. Adibhatla,et al. Role of Lipids in Brain Injury and Diseases. , 2007, Future lipidology.
[250] M. Ueno. Molecular anatomy of the brain endothelial barrier: an overview of the distributional features. , 2007, Current medicinal chemistry.
[251] P. Lewczuk,et al. International quality control survey of neurochemical dementia diagnostics , 2006, Neuroscience Letters.
[252] R. Al-Shahi,et al. CSF opening pressure: Reference interval and the effect of body mass index , 2006, Neurology.
[253] P. Solich,et al. Advantages of ultra performance liquid chromatography over high-performance liquid chromatography: comparison of different analytical approaches during analysis of diclofenac gel. , 2006, Journal of separation science.
[254] W. Huttner,et al. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells , 2005, Journal of Cell Science.
[255] Gavin Giovannoni,et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. , 2005, Archives of neurology.
[256] Jing Zhang,et al. Quantitative proteomic analysis of age-related changes in human cerebrospinal fluid , 2005, Neurobiology of Aging.
[257] S. Davies,et al. Molecular mechanisms of cerebrospinal fluid production , 2004, Neuroscience.
[258] J. Hoenicka,et al. The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.
[259] J. Ekelund,et al. No association between micrometer-sized particles in human cerebrospinal fluid and schizophrenia , 2003, Neuroscience Letters.
[260] Dean A Seehusen,et al. Cerebrospinal fluid analysis. , 2003, American family physician.
[261] A. Cruickshank,et al. National guidelines for analysis of cerebrospinal fluid for bilirubin in suspected subarachnoid haemorrhage , 2003, Annals of clinical biochemistry.
[262] R. Nitsch,et al. Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42. , 2003, Archives of neurology.
[263] Shant Kumar,et al. CD105 is important for angiogenesis: evidence and potential applications , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[264] T. Fladby,et al. Micrometer-sized particles in cerebrospinal fluid (CSF) in patients with schizophrenia , 2002, Neuroscience Letters.
[265] K. Blennow,et al. Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. , 2001, Clinical chemistry.
[266] B. Schlaggar,et al. Cerebrospinal fluid protein concentration in pediatric patients: defining clinically relevant reference values. , 2000, Archives of pediatrics & adolescent medicine.
[267] L. Hagberg,et al. Astroglial and neuronal proteins in cerebrospinal fluid as markers of CNS involvement in Lyme neuroborreliosis , 1999, European journal of neurology.
[268] C. Gibbs,et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. , 1996, The New England journal of medicine.
[269] Alejandra del C. Alonso,et al. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules , 1996, Nature Medicine.
[270] K. Blennow,et al. Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease? , 1995, Molecular and chemical neuropathology.
[271] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[272] J. Whitsett,et al. Effects of lung surfactant proteolipid SP-C on the organization of model membrane lipids: a fluorescence study. , 1992, Biochimica et biophysica acta.
[273] D. Teplow,et al. Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin , 1988, Nature.
[274] D. Dickson,et al. Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. , 1988, The American journal of pathology.
[275] K. Felgenhauer,et al. Development of the Blood‐CSF Barrier , 1983, Developmental medicine and child neurology.
[276] B. Weisner,et al. Protein fractions of lumbar, cisternal, and ventricular cerebrospinal fluid Separate areas of reference , 1978, Journal of the Neurological Sciences.
[277] W. J. Dyer,et al. A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.
[278] J. Folch,et al. A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.
[279] N. Hattori,et al. α-Synuclein Seeding Assay Using RT-QuIC. , 2021, Methods in molecular biology.
[280] Yasuhiko Kizuka,et al. Extracellular Vesicles and Glycosylation. , 2021, Advances in experimental medicine and biology.
[281] OUP accepted manuscript , 2021, Glycobiology.
[282] S. Realmuto,et al. Toxic effects on astrocytes of extracellular vesicles from CSF of multiple sclerosis patients: a pilot in vitro study. , 2020, Polish journal of pathology : official journal of the Polish Society of Pathologists.
[283] M. Pfaffl,et al. Propofol and Sevoflurane Differentially Impact MicroRNAs in Circulating Extracellular Vesicles during Colorectal Cancer Resection: A Pilot Study. , 2019, Anesthesiology.
[284] Virginia Claudio,et al. Methods for the physical characterization and quantification of extracellular vesicles in biological samples. , 2017, Biochimica et biophysica acta. General subjects.
[285] A. Jeromin,et al. Biomarkers in Neurodegenerative Diseases. , 2017, Advances in neurobiology.
[286] M. de Carvalho,et al. Phosphoneurofilament heavy chain and N-glycomics from the cerebrospinal fluid in amyotrophic lateral sclerosis. , 2015, Clinica chimica acta; international journal of clinical chemistry.
[287] G. Giovannoni. Cerebrospinal fluid analysis. , 2014, Handbook of clinical neurology.
[288] P. Lewczuk,et al. Ventricular and lumbar cerebrospinal fluid concentrations of Alzheimer's disease biomarkers in patients with normal pressure hydrocephalus and posttraumatic hydrocephalus. , 2014, Journal of Alzheimer's disease : JAD.
[289] J. Zorc,et al. Age-specific reference values for cerebrospinal fluid protein concentration in neonates and young infants. , 2011, Journal of hospital medicine.
[290] M. D. Del Bigio,et al. Ependymal cells: biology and pathology , 2009, Acta Neuropathologica.
[291] D. Wishart. Applications of Metabolomics in Drug Discovery and Development , 2008, Drugs in R&D.
[292] G. Schellenberg,et al. Effect of statins on Alzheimer's disease biomarkers in cerebrospinal fluid. , 2006, Journal of Alzheimer's disease : JAD.
[293] Mu Wang,et al. The impact of blood contamination on the proteome of cerebrospinal fluid , 2005, Proteomics.
[294] G. Freeman,et al. The B7 family revisited. , 2005, Annual review of immunology.
[295] R. Vassar. BACE1: the beta-secretase enzyme in Alzheimer's disease. , 2004, Journal of molecular neuroscience : MN.
[296] H. Reiber. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. , 2003, Restorative neurology and neuroscience.
[297] R. Broadwell. Pathways into, through, and around the fluid-brain barriers. , 1992, NIDA research monograph.
[298] K. Blennow,et al. Journal of Central Nervous System Disease , 2022 .